US2023050166A1PendingUtilityA1
Method to treat vitiligo
Assignee: APIRX PHARMACEUTICAL USA LLCPriority: Aug 28, 2017Filed: Sep 29, 2022Published: Feb 16, 2023
Est. expiryAug 28, 2037(~11.1 yrs left)· nominal 20-yr term from priority
A61K 36/74A61K 31/658A61K 36/24A61P 17/00A61K 9/0014A61K 31/728A61K 36/9066A61K 31/201A61K 36/58A61K 31/352A61K 31/05
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method to treat the skin condition vitiligo is described in this invention. The method comprises topical application of a composition containing cannabinoids, in particular cannabidiol and cannabigerol, at a concentration of 3%-20% by weight of the composition onto the affected skin area of a subject in need thereof. Application may be twice (2) daily for about six (6) weeks. Cannabidiol and cannabigerol may be sourced naturally or synthetically.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of treating vitiligo in a human in need thereof consisting essentially of topically administering to the human in need thereof a composition of more than 10 wt. % of cannabidiol and cannabigerol, wherein the human is administered low or trace amounts of Δ 9 tetrahydrocannabinol, and wherein the ratio of cannabigerol to cannabidiol is 2:1.
2 . The method of claim 1 , wherein the cannabidiol and cannabigerol are from a natural source.
3 . The method of claim 1 , wherein the cannabidiol and cannabigerol are synthetic.
4 . The method of claim 1 , wherein the cannabidiol and cannabigerol are in powder form prior to use.
5 . The method of claim 1 , wherein the cannabidiol and cannabigerol are in crystalline form prior to use.
6 . The method of claim 1 , wherein the cannabidiol and cannabigerol are microencapsulated.
7 . The method of claim 1 , wherein the cannabidiol and cannabigerol are nanoencapsulated with particle sizes of 20 to 40 nanometers.
8 . The method of claim 1 , wherein the cannabidiol and cannabigerol further consists essentially of sodium oleyl hyaluronate.
9 . The method of claim 1 , wherein the cannabidiol and cannabigerol further consist of at least one of omega-3 fatty acids or omega-6 fatty acids.
10 . The method of claim 1 , wherein the cannabidiol and cannabigerol further consist essentially of neem extract, Curcuma longa extract, Rubia cardifolia extract, or Wrightia tinctorial extract.
11 . The method of claim 1 , wherein the cannabidiol and cannabigerol further consist essentially of cacao butter.
12 . The method of claim 1 , wherein the cannabidiol and cannabigerol are in a hydro gel form, a liquid form, a spray form, a powder form, or an ointment form.
13 . The method of claim 1 , wherein the cannabidiol and cannabigerol are applied twice daily for six weeks onto affected skin areas of a human suffering from vitiligo.Join the waitlist — get patent alerts
Track US2023050166A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.